Braidwell »

Beauty Health shares owned by Braidwell

Quarter-by-quarter ownership of Beauty Health (SKIN) shares owned by Braidwell from 13F filings

Historical chart of Braidwell investment in Beauty Health

Tip: Access up to 7 years of quarterly data

All positions including Beauty Health held by Braidwell consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Beauty Health by Braidwell

Quarter filed Position value Share count Share price at filing
2024-09-30 $5.8M 4.0M 1.44
2024-06-30 $9.8M 5.1M 1.92
2023-09-30 $9.8M 1.6M 6.02

More positions owned by Braidwell

Guardant Health Note11/1 (Principal)
Bridgebio Pharma Note 2.500% 3/1 (Principal)
Novocure Note11/0 (Principal)
Cg Oncology (CGON)
Nuvasive Note 0.375% 3/1 (Principal)
Xenon Pharmaceuticals (XENE)
Neurocrine Biosciences (NBIX)
Neogenomics Note 0.250% 1/1 (Principal)
Apogee Therapeutics (APGE)
Apellis Pharmaceuticals (APLS)
Ironwood Pharmaceuticals Note 1.500% 6/1 (Principal)
Dexcom Note 0.375% 5/1 (Principal)
Align Technology (ALGN)
Guardant Health (GH)
Insulet Corp Note 0.375% 9/0 (Principal)

View all positions for Braidwell

Top funds holding Beauty Health

Henderson Group
BlackRock
BlackRock
Vanguard Group
Braidwell
Divisadero Street Capital Management
Jacobs Levy Equity Management
Geode Capital Management
D. E. Shaw & Co
State Street Corporation
Soleus Capital Management
Silver Point Capital
ExodusPoint Capital Management
Woodline Partners
Kent Lake Capital

View all funds holding Beauty Health